M
MiLaboratories
Top-notch solutions for adaptive immunity studies
About MiLaboratories
MiLaboratories LLC specializes in providing advanced solutions for the analysis of adaptive immunity, focusing on immune repertoire sequencing. The company serves researchers and clinicians involved in vaccine development, cancer research, antibody discovery, and autoimmune disease studies. Operating in the bioinformatics and biotechnology markets, MiLaboratories offers a comprehensive suite of tools, including the MiXCR software, which is designed to analyze, visualize, and interpret immune repertoire sequencing data. The business model revolves around software licensing and service contracts, generating revenue through the sale of its proprietary software and associated services. MiLaboratories' strategic partnerships, such as the one with ENPICOM, enhance its offerings by integrating cloud-based data management and user-friendly interfaces.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- San Francisco, United States
- Employees
- 26
- Open positions
- 1
- Dealroom signal
- 81.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Core AI, Spinout, AI Drug Discovery, Techbio, Techbio Drug Discovery, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2024 | $11M | $44M | Speedinvest · K Fund · Acrobator Ventures · EGB Capital | ↗ |
| SEED✓Equity / VC | Feb 2022 | $2.6M | $11M | Speedinvest · Acrobator Ventures | — |
Growth signals
Latest recorded traffic for MiLaboratories is 3.9K monthly website visits, up 2500% over the last three months. MiLaboratories's team grew 23.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Speedinvest
Acrobator Ventures
Series A5 investors entered at this stage
K Fund
EGB Capital
TEN13
Courtyard Ventures
Somersault Ventures
Other known investors2 additional known investors
Shemyakin–Ovchinnikov Institute of bioorganic chemistry RAS- BIBio
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MiLaboratories on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MiLaboratories’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.